Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wei-guo Long"'
Autor:
Wei-guo Long, Qian-li Zhang, Wen-xia Jiang, Yi-yan Zhang, Sheng-chun Dang, Jian-nong Wu, An-jing Zhong, Jin Wu, Jun-wu Yang
Publikováno v:
Human Pathology Reports, Vol 26, Iss , Pp 300549- (2021)
The presence of ectopic prostatic tissue (EPT) in the female reproductive system has rarely been reported. To date, only a little more than 10 cases have been documented. Herein, we report a case of EPT detected in the uterine cervix of a 72-year-old
Externí odkaz:
https://doaj.org/article/11c7c5d463c444cea6be3b0ef2b0aeaa
Autor:
Ping Chen, Han-Peng Huang, Yi Wang, Jun Jin, Wei-Guo Long, Kan Chen, Xiao-Hui Zhao, Chen-Guo Chen, Jian Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Abstract Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary res
Externí odkaz:
https://doaj.org/article/fe6848e03c674fe7b583c283c387e6c7
Autor:
Yi Wang, Chen-Guo Chen, Xiao-Qin Li, Wei-Guo Long, Jin-Yu Su, Jing Ren, Yu-Min Zhu, Qian Jiang, Jian Li
Publikováno v:
Cellular Oncology. 44:135-150
Paclitaxel is an anticancer drug for the treatment of non-small cell lung cancer (NSCLC). However, drug-resistance remains a major problem. Honokiol is a natural component which has been found to exhibit anti-tumor activity. Paclitaxel and honokiol h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb75df21985d8231e24f638a8f75dd0
https://doi.org/10.1007/s13402-020-00557-x
https://doi.org/10.1007/s13402-020-00557-x
Autor:
Yang Shu, Rong-Xia Yuan, Jian-Nong Wu, Yu-Min Zhu, Jian Li, Wei-Guo Long, Li-Haun Zhu, Chun-Hua Dai, Ping Chen
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864:3786-3798
Resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as erlotinib and gefitinib, is a major clinical problem in the treatment of patients with non-small cell lung cancer (NSCLC). YM155 is a survivin small molecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa172a8793c409c69babe131fca701eb
https://doi.org/10.1016/j.bbadis.2018.10.015
https://doi.org/10.1016/j.bbadis.2018.10.015
Autor:
Chen-Guo Chen, Jun Jin, Yi Wang, Wei-Guo Long, Kan Chen, Xiaohui Zhao, Han-Peng Huang, Ping Chen, Jian Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary resistant to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a592e1baa1cc3f3b4eaf25f7fbd4206
http://europepmc.org/articles/PMC6567416
http://europepmc.org/articles/PMC6567416
Publikováno v:
AME Case Rep
Infantile digital fibromatosis is a rare, benign fibrous tumor among infants usually limited to fingers and toes. Most cases present themselves with round eosinophilic inclusion bodies of different sizes, similar to erythrocyte in the parakarytoplasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf98574fa30269f9976fc1af0efb8e1b
https://doi.org/10.21037/acr-20-95
https://doi.org/10.21037/acr-20-95
Publikováno v:
Chinese Journal of Eco-Agriculture. 19:548-553
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a7658bc458aecb190699d65490dee3
https://doi.org/10.3724/sp.j.1011.2011.00548
https://doi.org/10.3724/sp.j.1011.2011.00548